{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:25:06Z","timestamp":1794641106920,"version":"4.9.1"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ferroptosis is a distinct form of regulated cell death driven by iron-dependent lipid peroxidation and oxidative membrane damage, and it differs fundamentally from apoptosis, necroptosis, and pyroptosis in its molecular mechanisms and execution pathways. Increasing evidence indicates that ferroptosis plays a pivotal role in cancer biology by regulating tumour initiation, progression, metastasis, therapeutic resistance, and interactions within the tumour microenvironment (TME). Dysregulation of iron metabolism, lipid peroxidation, amino acid metabolism, and antioxidant defence systems, including the System Xc\u207b\u2013GSH\u2013GPX4, FSP1\u2013CoQ\u2081\u2080, GCH1\u2013BH4, and DHODH pathways, collectively determines cellular susceptibility to ferroptosis. Recent studies have further highlighted the contribution of organelle crosstalk, immune cell regulation, and stromal interactions in shaping ferroptotic responses and tumour evolution. In this review, we comprehensively summarise the molecular mechanisms underlying ferroptosis, its regulatory signalling networks, and the major milestones that have advanced the field. We further discuss the multifaceted role of ferroptosis across diverse malignancies, its influence on epithelial\u2013mesenchymal transition, tumour invasion, metastasis, and immune modulation, and its emerging significance in overcoming resistance to chemotherapy, radiotherapy, targeted therapy, and immunotherapy. In addition, we critically evaluate recent progress in ferroptosis-based therapeutic strategies, including nanomedicine, combination therapies, and translational advances, while highlighting current clinical challenges such as tumour heterogeneity, limited pharmacodynamic biomarkers, and safety concerns. Collectively, ferroptosis represents a promising therapeutic vulnerability that bridges fundamental cancer biology with precision oncology. Continued development of biomarker-guided patient stratification, targeted drug delivery systems, and rational combination strategies is expected to accelerate the clinical translation of ferroptosis-based therapies and improve outcomes for patients with refractory and treatment-resistant cancers.<\/jats:p>","DOI":"10.1186\/s43046-026-00419-x","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:26:02Z","timestamp":1792229162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ferroptosis in cancer: molecular mechanisms, tumour microenvironment, therapeutic resistance, and clinical translation"],"prefix":"10.1186","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5879-7165","authenticated-orcid":false,"given":"Ghisaram","family":"Dewasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"issue":"1","key":"419_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9(1):55\u201355. https:\/\/doi.org\/10.1038\/s41392-024-01769-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"419_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"P Fu","year":"2022","unstructured":"Fu P, Liao M, Qin R, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1):286\u2013286. https:\/\/doi.org\/10.1038\/s41392-022-01110-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"419_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1158\/2159-8290.cd-20-0789","volume":"11","author":"E Koren","year":"2021","unstructured":"Koren E, Fuchs Y. Modes of Regulated Cell Death in Cancer. Cancer Discov. 2021;11(2):245\u201365. https:\/\/doi.org\/10.1158\/2159-8290.cd-20-0789.","journal-title":"Cancer Discov"},{"issue":"6","key":"419_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/med.21398","volume":"36","author":"B Ke","year":"2016","unstructured":"Ke B, Tian M, Li J, Liu B, He G. Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy. Med Res Rev. 2016;36(6):983\u20131035. https:\/\/doi.org\/10.1002\/med.21398.","journal-title":"Med Res Rev"},{"key":"419_CR5","doi-asserted-by":"publisher","first-page":"1416115","DOI":"10.3389\/fcell.2024.1416115","volume":"12","author":"J Lu","year":"2024","unstructured":"Lu J, He R, Liu Y, et al. Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions. Front Cell Dev Biol. 2024;12:1416115\u20131416115. https:\/\/doi.org\/10.3389\/fcell.2024.1416115.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"419_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2015","unstructured":"Yang WS, Stockwell BR, Ferroptosis. Death by Lipid Peroxidation. Trends Cell Biol. 2015;26(3):165\u201376. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.014.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"419_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms24010449","volume":"24","author":"L Rochette","year":"2022","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. Int J Mol Sci. 2022;24(1):449\u2013449. https:\/\/doi.org\/10.3390\/ijms24010449.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"419_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12943-024-01999-9","volume":"23","author":"J Diao","year":"2024","unstructured":"Diao J, Jia Y, Dai E, et al. Ferroptotic therapy in cancer: benefits, side effects, and risks. Mol Cancer. 2024;23(1):89\u201389. https:\/\/doi.org\/10.1186\/s12943-024-01999-9.","journal-title":"Mol Cancer"},{"issue":"1","key":"419_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","volume":"10","author":"X Jin","year":"2024","unstructured":"Jin X, Tang J, Qiu X, et al. Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. Cell Death Discov. 2024;10(1):45\u201345. https:\/\/doi.org\/10.1038\/s41420-024-01825-7.","journal-title":"Cell Death Discov"},{"issue":"1","key":"419_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34\u201334. https:\/\/doi.org\/10.1186\/s13045-019-0720-y.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"419_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41556-020-0565-1","volume":"22","author":"M Riegman","year":"2020","unstructured":"Riegman M, Sagie L, Galed C, et al. Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture. Nat Cell Biol. 2020;22(9):1042\u20138. https:\/\/doi.org\/10.1038\/s41556-020-0565-1. (PMID: 32868903).","journal-title":"Nat Cell Biol"},{"issue":"7","key":"419_CR12","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cub.2023.02.060","volume":"33","author":"Y Hirata","year":"2023","unstructured":"Hirata Y, Cai R, Volchuk A, et al. Lipid peroxidation increases membrane tension, Piezo1 gating, and cation permeability to execute ferroptosis. Curr Biol. 2023;33(7):1282\u201394. https:\/\/doi.org\/10.1016\/j.cub.2023.02.060.","journal-title":"Curr Biol"},{"issue":"5","key":"419_CR13","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41418-020-00691-x","volume":"28","author":"L Pedrera","year":"2021","unstructured":"Pedrera L, Espiritu RA, Ros U, et al. Ferroptotic pores induce Ca\u00b2\u207a fluxes and ESCRT-III activation to modulate cell death kinetics. Cell Death Differ. 2021;28(5):1644\u201357. https:\/\/doi.org\/10.1038\/s41418-020-00691-x.","journal-title":"Cell Death Differ"},{"key":"419_CR14","doi-asserted-by":"publisher","unstructured":"Feng H, Stockwell BR. Unsolved mysteries: How does lipid peroxidation cause ferroptosis? PLoS Biol. 2018;16(5). https:\/\/doi.org\/10.1371\/journal.pbio.2006203.","DOI":"10.1371\/journal.pbio.2006203"},{"issue":"2","key":"419_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2020","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2020;31(2):107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1.","journal-title":"Cell Res"},{"key":"419_CR16","doi-asserted-by":"publisher","first-page":"103211","DOI":"10.1016\/j.redox.2024.103211","volume":"75","author":"C Berndt","year":"2024","unstructured":"Berndt C, Alborzinia H, Amen VS, et al. Ferroptosis in health and disease. Redox Biol. 2024;75:103211\u2013103211. https:\/\/doi.org\/10.1016\/j.redox.2024.103211.","journal-title":"Redox Biol"},{"issue":"1","key":"419_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/cancers12010164","volume":"12","author":"CM Bebber","year":"2020","unstructured":"Bebber CM, M\u00fcller F, Clemente LP, Weber J, von Karstedt S. Ferroptosis Cancer Cell Biology Cancers. 2020;12(1):164\u2013164. https:\/\/doi.org\/10.3390\/cancers12010164.","journal-title":"Ferroptosis Cancer Cell Biology Cancers"},{"key":"419_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","volume":"133","author":"T Hirschhorn","year":"2018","unstructured":"Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2018;133:130\u201343. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.043.","journal-title":"Free Radic Biol Med"},{"key":"419_CR19","doi-asserted-by":"publisher","first-page":"909821","DOI":"10.3389\/fphar.2022.909821","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang Y, Wu X, et al. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer. Front Pharmacol. 2022;13:909821\u2013909821. https:\/\/doi.org\/10.3389\/fphar.2022.909821.","journal-title":"Front Pharmacol"},{"issue":"7","key":"419_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Wang W, Razak SRA, Han T, Ahmad NH, Li X. Ferroptosis as a potential target for cancer therapy. Cell Death Dis. 2023;14(7):460\u2013460. https:\/\/doi.org\/10.1038\/s41419-023-05930-w.","journal-title":"Cell Death Dis"},{"key":"419_CR21","doi-asserted-by":"publisher","first-page":"629150","DOI":"10.3389\/fcell.2021.629150","volume":"9","author":"H Wang","year":"2021","unstructured":"Wang H, Lin D, Yu Q, et al. A Promising Future of Ferroptosis in Tumor Therapy. Front Cell Dev Biol. 2021;9:629150\u2013629150. https:\/\/doi.org\/10.3389\/fcell.2021.629150.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"419_CR22","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.3390\/ijms27052232","volume":"27","author":"JL Bucarey","year":"2026","unstructured":"Bucarey JL, Casas M, Espinosa A. Mitochondrial Iron Handling and Lipid Peroxidation as Drivers of Ferroptosis. Int J Mol Sci. 2026;27(5):2232\u20132232. https:\/\/doi.org\/10.3390\/ijms27052232.","journal-title":"Int J Mol Sci"},{"key":"419_CR23","doi-asserted-by":"publisher","first-page":"1196287","DOI":"10.3389\/fphar.2023.1196287","volume":"14","author":"Y Lu","year":"2023","unstructured":"Lu Y, Hu J, Chen L, et al. Ferroptosis as an emerging therapeutic target in liver diseases. Front Pharmacol. 2023;14:1196287\u20131196287. https:\/\/doi.org\/10.3389\/fphar.2023.1196287.","journal-title":"Front Pharmacol"},{"issue":"2","key":"419_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun. 2022;42(2):88\u2013116. https:\/\/doi.org\/10.1002\/cac2.12250.","journal-title":"Cancer Commun"},{"issue":"3","key":"419_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00204-023-03660-8","volume":"98","author":"Y Xiang","year":"2024","unstructured":"Xiang Y, Song X, Long D. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases. Arch Toxicol. 2024;98(3):579\u2013615. https:\/\/doi.org\/10.1007\/s00204-023-03660-8.","journal-title":"Arch Toxicol"},{"key":"419_CR26","doi-asserted-by":"publisher","unstructured":"Jyotsana N, Ta KTL, DelGiorno KE. The Role of Cystine\/Glutamate Antiporter SLC7A11\/xCT in the Pathophysiology of Cancer. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.858462.","DOI":"10.3389\/fonc.2022.858462"},{"key":"419_CR27","doi-asserted-by":"publisher","first-page":"1434088","DOI":"10.3389\/fphar.2024.1434088","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu J, Shi Y, Zhou M, et al. Nutrient vitamins enabled metabolic regulation of ferroptosis via reactive oxygen species biology. Front Pharmacol. 2024;15:1434088\u20131434088. https:\/\/doi.org\/10.3389\/fphar.2024.1434088.","journal-title":"Front Pharmacol"},{"issue":"2","key":"419_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin H, liang, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88\u201388. https:\/\/doi.org\/10.1038\/s41419-020-2298-2.","journal-title":"Cell Death Dis"},{"key":"419_CR29","doi-asserted-by":"publisher","unstructured":"Bai C, Hua J, Meng D, et al. Glutaminase-1 Mediated Glutaminolysis to Glutathione Synthesis Maintains Redox Homeostasis and Modulates Ferroptosis Sensitivity in Cancer Cells. Cell Prolif. 2025;58(11). https:\/\/doi.org\/10.1111\/cpr.70036.","DOI":"10.1111\/cpr.70036"},{"key":"419_CR30","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao JY, Dixon SJ. Mechanisms of ferroptosis. Cell Mol Life Sci. 2016;73:2195\u2013209. https:\/\/doi.org\/10.1007\/s00018-016-2194-1.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"419_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nchembio.2079","volume":"12","author":"K Shimada","year":"2016","unstructured":"Shimada K, Skouta R, Kaplan A, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 2016;12(7):497\u2013503. https:\/\/doi.org\/10.1038\/nchembio.2079.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"419_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s42255-020-0181-1","volume":"2","author":"CC Ding","year":"2020","unstructured":"Ding CC, Rose J, Sun T, et al. MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis. Nat Metab. 2020;2(3):270\u20137. https:\/\/doi.org\/10.1038\/s42255-020-0181-1.","journal-title":"Nat Metab"},{"key":"419_CR33","doi-asserted-by":"publisher","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59(2):298\u2013308. https:\/\/doi.org\/10.1016\/j.molcel.2015.06.011 (PMID: 26166707).","DOI":"10.1016\/j.molcel.2015.06.011"},{"issue":"2","key":"419_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee H, Zandkarimi F, Zhang Y, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22(2):225\u201334. https:\/\/doi.org\/10.1038\/s41556-020-0461-8.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"419_CR35","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula M, Weber RA, Zilka O, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16(12):1351\u201360. https:\/\/doi.org\/10.1038\/s41589-020-0613-y.","journal-title":"Nat Chem Biol"},{"issue":"7860","key":"419_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390. https:\/\/doi.org\/10.1038\/s41586-021-03539-7.","journal-title":"Nature"},{"issue":"1","key":"419_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41420-024-02078-0","volume":"10","author":"Y Hu","year":"2024","unstructured":"Hu Y, Huang Y, Zong L, Lin J, Liu X, Ning S. Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges. Cell Death Discov. 2024;10(1):301\u2013301. https:\/\/doi.org\/10.1038\/s41420-024-02078-0.","journal-title":"Cell Death Discov"},{"issue":"7","key":"419_CR38","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41419-023-05978-8","volume":"14","author":"S Lee","year":"2023","unstructured":"Lee S, Hwang N, Seok BG, Lee S, Lee S, Chung SW. Autophagy mediates an amplification loop during ferroptosis. Cell Death Dis. 2023;14(7):464\u2013464. https:\/\/doi.org\/10.1038\/s41419-023-05978-8.","journal-title":"Cell Death Dis"},{"issue":"1","key":"419_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Hu J, Wu S, et al. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. Signal Transduct Target Ther. 2023;8(1):449\u2013449. https:\/\/doi.org\/10.1038\/s41392-023-01720-0.","journal-title":"Signal Transduct Target Ther"},{"key":"419_CR40","doi-asserted-by":"publisher","first-page":"765859","DOI":"10.3389\/fcell.2021.765859","volume":"9","author":"Z Tang","year":"2021","unstructured":"Tang Z, Huang Z, Huang Y, et al. Ferroptosis: The Silver Lining of Cancer Therapy. Front Cell Dev Biol. 2021;9:765859\u2013765859. https:\/\/doi.org\/10.3389\/fcell.2021.765859.","journal-title":"Front Cell Dev Biol"},{"key":"419_CR41","doi-asserted-by":"publisher","first-page":"1007446","DOI":"10.3389\/fonc.2022.1007446","volume":"12","author":"Y Yang","year":"2022","unstructured":"Yang Y, Wang M, Zhang Y, Zhao S, Gu S. The endosomal sorting complex required for transport repairs the membrane to delay cell death. Front Oncol. 2022;12:1007446\u20131007446. https:\/\/doi.org\/10.3389\/fonc.2022.1007446.","journal-title":"Front Oncol"},{"issue":"1","key":"419_CR42","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8(1):372\u2013372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"7784","key":"419_CR43","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392. https:\/\/doi.org\/10.1038\/s41586-019-1705-2.","journal-title":"Nature"},{"issue":"7784","key":"419_CR44","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1707-0.","journal-title":"Nature"},{"issue":"1","key":"419_CR45","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, Lei G, Zhang Y, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022;13(1):2206. https:\/\/doi.org\/10.1038\/s41467-022-29905-1.","journal-title":"Nat Commun"},{"issue":"1","key":"419_CR46","doi-asserted-by":"publisher","first-page":"eaea8771","DOI":"10.1126\/sciadv.aea8771","volume":"12","author":"M Higuchi","year":"2026","unstructured":"Higuchi M, Hangauer MJ, Viswanathan VS, et al. FSP1 and histone deacetylases suppress cancer persister cell ferroptosis. Sci Adv. 2026;12(1):eaea8771. https:\/\/doi.org\/10.1126\/sciadv.aea8771.","journal-title":"Sci Adv"},{"issue":"9","key":"419_CR47","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.chembiol.2023.04.007","volume":"30","author":"JM Hendricks","year":"2023","unstructured":"Hendricks JM, Doubravsky CE, Wehri E, et al. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Cell Chem Biol. 2023;30(9):1090\u2013e11037. https:\/\/doi.org\/10.1016\/j.chembiol.2023.04.007.","journal-title":"Cell Chem Biol"},{"issue":"3","key":"419_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, Ko PJ, To M, et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem Biol. 2019;26(3):420\u2013e4329. https:\/\/doi.org\/10.1016\/j.chembiol.2018.11.016.","journal-title":"Cell Chem Biol"},{"issue":"2","key":"419_CR49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/lifemeta\/loac035","volume":"1","author":"J Guo","year":"2022","unstructured":"Guo J, Zhou Y, Liu D, et al. Mitochondria as multifaceted regulators of ferroptosis. Life Metab. 2022;1(2):134\u201348. https:\/\/doi.org\/10.1093\/lifemeta\/loac035.","journal-title":"Life Metab"},{"key":"419_CR50","doi-asserted-by":"publisher","unstructured":"Zhang R, Kroemer G, Tang D. Lipid-derived radical-trapping antioxidants suppress ferroptosis. Life Metab. 2024;3(2). https:\/\/doi.org\/10.1093\/lifemeta\/loae008.","DOI":"10.1093\/lifemeta\/loae008"},{"issue":"1","key":"419_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves F, Lane DJR, Nguyen TPM, Bush AI, Ayton S. In defence of ferroptosis. Signal Transduct Target Ther. 2025;10(1):2\u20132. https:\/\/doi.org\/10.1038\/s41392-024-02088-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"419_CR52","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cells9061505","volume":"9","author":"AM Battaglia","year":"2020","unstructured":"Battaglia AM, Chirillo R, Aversa I, Sacco A, Costanzo F, Biamonte F. Ferroptosis and Cancer: Mitochondria Meet the Iron Maiden. Cell Death Cells. 2020;9(6):1505\u20131505. https:\/\/doi.org\/10.3390\/cells9061505.","journal-title":"Cell Death Cells"},{"issue":"5","key":"419_CR53","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.7150\/ijbs.105446","volume":"21","author":"Z Ding","year":"2025","unstructured":"Ding Z, Li Z, Sun K, et al. Mitochondrial Regulation of Ferroptosis in Cancer Cells. Int J Biol Sci. 2025;21(5):2179\u2013200. https:\/\/doi.org\/10.7150\/ijbs.105446.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"419_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan HF, Zou T, Tuo Q, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6(1):49\u201349. https:\/\/doi.org\/10.1038\/s41392-020-00428-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"419_CR55","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/bph.15350","volume":"178","author":"Z Wang","year":"2020","unstructured":"Wang Z, Ma J, Li X, et al. Quercetin induces p53-independent cancer cell death through lysosome activation by the transcription factor EB and Reactive Oxygen Species\u2010dependent ferroptosis. Br J Pharmacol. 2020;178(5):1133\u201348. https:\/\/doi.org\/10.1111\/bph.15350.","journal-title":"Br J Pharmacol"},{"key":"419_CR56","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, Tang D. Iron Metabolism in Ferroptosis. Front Cell Dev Biol. 2020;8:590226\u2013590226. https:\/\/doi.org\/10.3389\/fcell.2020.590226.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"419_CR57","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41419-020-03032-5","volume":"11","author":"S Zhu","year":"2020","unstructured":"Zhu S, Yao R, qi, Li Y, et al. Lysosomal quality control of cell fate: a novel therapeutic target for human diseases. Cell Death Dis. 2020;11(9):817\u2013817. https:\/\/doi.org\/10.1038\/s41419-020-03032-5.","journal-title":"Cell Death Dis"},{"issue":"6","key":"419_CR58","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1042\/bj20150658","volume":"473","author":"S Torii","year":"2016","unstructured":"Torii S, Shintoku R, Kubota C, et al. An essential role for functional lysosomes in ferroptosis of cancer cells. Biochem J. 2016;473(6):769\u201377. https:\/\/doi.org\/10.1042\/bj20150658.","journal-title":"Biochem J"},{"issue":"1","key":"419_CR59","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41392-021-00613-4","volume":"6","author":"R Zhang","year":"2021","unstructured":"Zhang R, Kang R, Tang D. The STING1 network regulates autophagy and cell death. Signal Transduct Target Ther. 2021;6(1):208\u2013208. https:\/\/doi.org\/10.1038\/s41392-021-00613-4.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"419_CR60","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu SP, Wu L, Yang L, Yang L, Wang J. The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 2023;14(8):519\u2013519. https:\/\/doi.org\/10.1038\/s41419-023-06045-y.","journal-title":"Cell Death Dis"},{"issue":"1","key":"419_CR61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41420-022-01218-8","volume":"8","author":"D Gong","year":"2022","unstructured":"Gong D, Chen M, Wang Y, Shi J, Hou Y. Role of ferroptosis on tumor progression and immunotherapy. Cell Death Discov. 2022;8(1):427\u2013427. https:\/\/doi.org\/10.1038\/s41420-022-01218-8.","journal-title":"Cell Death Discov"},{"key":"419_CR62","doi-asserted-by":"publisher","first-page":"905501","DOI":"10.3389\/fphar.2022.905501","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li M, Guo Y, Liu S, Tao Y. The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis. Front Pharmacol. 2022;13:905501\u2013905501. https:\/\/doi.org\/10.3389\/fphar.2022.905501.","journal-title":"Front Pharmacol"},{"key":"419_CR63","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ceb.2017.03.008","volume":"47","author":"J Wei","year":"2017","unstructured":"Wei J, Seemann J. Golgi ribbon disassembly during mitosis, differentiation and disease progression. Curr Opin Cell Biol. 2017;47:43\u201351. https:\/\/doi.org\/10.1016\/j.ceb.2017.03.008.","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"419_CR64","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1074\/jbc.m807263200","volume":"284","author":"S Mukherjee","year":"2008","unstructured":"Mukherjee S, Shields D. Nuclear Import Is Required for the Pro-apoptotic Function of the Golgi Protein p115. J Biol Chem. 2008;284(3):1709\u201317. https:\/\/doi.org\/10.1074\/jbc.m807263200.","journal-title":"J Biol Chem"},{"issue":"10","key":"419_CR65","doi-asserted-by":"publisher","first-page":"8565","DOI":"10.1074\/jbc.m110.175174","volume":"286","author":"PC How","year":"2010","unstructured":"How PC, Shields D. Tethering Function of the Caspase Cleavage Fragment of Golgi Protein p115 Promotes Apoptosis via a p53-dependent Pathway. J Biol Chem. 2010;286(10):8565\u201376. https:\/\/doi.org\/10.1074\/jbc.m110.175174.","journal-title":"J Biol Chem"},{"issue":"12","key":"419_CR66","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.7150\/ijbs.85674","volume":"19","author":"Q Feng","year":"2023","unstructured":"Feng Q, Yang Y, Ren K, et al. Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases. Int J Biol Sci. 2023;19(12):3726\u201343. https:\/\/doi.org\/10.7150\/ijbs.85674.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"419_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1247\/csf.14015","volume":"40","author":"M Taniguchi","year":"2014","unstructured":"Taniguchi M, Nadanaka S, Tanakura S, et al. TFE3 Is a bHLH-ZIP-type Transcription Factor that Regulates the Mammalian Golgi Stress Response. Cell Struct Funct. 2014;40(1):13\u201330. https:\/\/doi.org\/10.1247\/csf.14015.","journal-title":"Cell Struct Funct"},{"issue":"6","key":"419_CR68","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41556-025-01668-z","volume":"27","author":"ML Sassano","year":"2025","unstructured":"Sassano ML, Tyurina YY, Diokmetzidou A, et al. Endoplasmic reticulum\u2013mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis. Nat Cell Biol. 2025;27(6):902\u201317. https:\/\/doi.org\/10.1038\/s41556-025-01668-z.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"419_CR69","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1038\/s41467-024-48330-0","volume":"15","author":"D Jiang","year":"2024","unstructured":"Jiang D, Guo Y, Wang T, et al. IRE1\u03b1 determines ferroptosis sensitivity through regulation of glutathione synthesis. Nat Commun. 2024;15(1):4114\u20134114. https:\/\/doi.org\/10.1038\/s41467-024-48330-0.","journal-title":"Nat Commun"},{"key":"419_CR70","doi-asserted-by":"publisher","first-page":"1359453","DOI":"10.3389\/fncel.2024.1359453","volume":"18","author":"L Wang","year":"2024","unstructured":"Wang L, Fang X, Ling B, et al. Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases. Front Cell Neurosci. 2024;18:1359453\u20131359453. https:\/\/doi.org\/10.3389\/fncel.2024.1359453.","journal-title":"Front Cell Neurosci"},{"key":"419_CR71","doi-asserted-by":"publisher","first-page":"1594419","DOI":"10.3389\/fphar.2025.1594419","volume":"16","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Zhang M, Sun M. ACSL4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis. Front Pharmacol. 2025;16:1594419\u20131594419. https:\/\/doi.org\/10.3389\/fphar.2025.1594419.","journal-title":"Front Pharmacol"},{"key":"419_CR72","doi-asserted-by":"publisher","first-page":"879317","DOI":"10.3389\/fphar.2022.879317","volume":"13","author":"Z Nie","year":"2022","unstructured":"Nie Z, Chen M, Gao Y, et al. Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges. Front Pharmacol. 2022;13:879317\u2013879317. https:\/\/doi.org\/10.3389\/fphar.2022.879317.","journal-title":"Front Pharmacol"},{"issue":"4","key":"419_CR73","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1152\/physrev.00031.2007","volume":"88","author":"SK Powers","year":"2008","unstructured":"Powers SK, Jackson MJ. Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production. Physiol Rev. 2008;88(4):1243\u201376. https:\/\/doi.org\/10.1152\/physrev.00031.2007.","journal-title":"Physiol Rev"},{"issue":"1","key":"419_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-020-01157-x","volume":"19","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhang SW, Gong X, et al. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression. Mol Cancer. 2020;19(1):39\u201339. https:\/\/doi.org\/10.1186\/s12943-020-01157-x.","journal-title":"Mol Cancer"},{"key":"419_CR75","doi-asserted-by":"publisher","first-page":"1188365","DOI":"10.3389\/fimmu.2023.1188365","volume":"14","author":"D Qi","year":"2023","unstructured":"Qi D, Peng M. Ferroptosis-mediated immune responses in cancer. Front Immunol. 2023;14:1188365\u20131188365. https:\/\/doi.org\/10.3389\/fimmu.2023.1188365.","journal-title":"Front Immunol"},{"issue":"1","key":"419_CR76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41420-024-02037-9","volume":"10","author":"S Wang","year":"2024","unstructured":"Wang S, Guo Q, Zhou L, Xia X, Ferroptosis. A double-edged sword. Cell Death Discov. 2024;10(1):265\u2013265. https:\/\/doi.org\/10.1038\/s41420-024-02037-9.","journal-title":"Cell Death Discov"},{"key":"419_CR77","doi-asserted-by":"publisher","first-page":"1346585","DOI":"10.3389\/fimmu.2024.1346585","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Liu Y, Che S, et al. Deciphering the link: ferroptosis and its role in glioma. Front Immunol. 2024;15:1346585\u20131346585. https:\/\/doi.org\/10.3389\/fimmu.2024.1346585.","journal-title":"Front Immunol"},{"key":"419_CR78","doi-asserted-by":"publisher","unstructured":"Shen Z, Song J, Yung BC, Zhou Z, Wu A, Chen X. Emerging Strategies of Cancer Therapy Based on Ferroptosis. Adv Mater. 2018;30(12). https:\/\/doi.org\/10.1002\/adma.201704007.","DOI":"10.1002\/adma.201704007"},{"issue":"1","key":"419_CR79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47\u201347. https:\/\/doi.org\/10.1186\/s12943-022-01530-y.","journal-title":"Mol Cancer"},{"key":"419_CR80","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fphar.2017.00992","volume":"8","author":"B Lu","year":"2018","unstructured":"Lu B, Chen XB, Ying MD, He Q, Cao J, Yang B. The Role of Ferroptosis in Cancer Development and Treatment Response. Front Pharmacol. 2018;8:992\u2013992. https:\/\/doi.org\/10.3389\/fphar.2017.00992.","journal-title":"Front Pharmacol"},{"issue":"12","key":"419_CR81","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180\u201391. https:\/\/doi.org\/10.1038\/ncb3064. (PMID: 25402683).","journal-title":"Nat Cell Biol"},{"issue":"7","key":"419_CR82","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon SJ, Winter GE, Musavi L, et al. Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS Chem Biol. 2015;10(7):1604\u20139. https:\/\/doi.org\/10.1021\/acschembio.5b00245.","journal-title":"ACS Chem Biol"},{"issue":"8","key":"419_CR83","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41419-022-05137-5","volume":"13","author":"J Grube","year":"2022","unstructured":"Grube J, Woitok MM, Mohs A, et al. ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression. Cell Death Dis. 2022;13(8):704\u2013704. https:\/\/doi.org\/10.1038\/s41419-022-05137-5.","journal-title":"Cell Death Dis"},{"issue":"1","key":"419_CR84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","volume":"17","author":"F Chen","year":"2024","unstructured":"Chen F, Kang R, Tang D, Liu J. Ferroptosis: principles and significance in health and disease. J Hematol Oncol. 2024;17(1):41\u201341. https:\/\/doi.org\/10.1186\/s13045-024-01564-3.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"419_CR85","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3892\/ol.2024.14437","volume":"28","author":"L Zeng","year":"2024","unstructured":"Zeng L, Liu X, Geng C, Gao X, Liu L. Ferroptosis in cancer (Review). Oncol Lett. 2024;28(1):304\u2013304. https:\/\/doi.org\/10.3892\/ol.2024.14437.","journal-title":"Oncol Lett"},{"key":"419_CR86","doi-asserted-by":"publisher","first-page":"1038225","DOI":"10.3389\/fimmu.2022.1038225","volume":"13","author":"X Qi","year":"2022","unstructured":"Qi X, Wan Z, Jiang B, et al. Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer. Front Immunol. 2022;13:1038225\u20131038225. https:\/\/doi.org\/10.3389\/fimmu.2022.1038225.","journal-title":"Front Immunol"},{"issue":"1","key":"419_CR87","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6(1):41\u201353. https:\/\/doi.org\/10.1021\/acscentsci.9b01063.","journal-title":"ACS Cent Sci"},{"issue":"7826","key":"419_CR88","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, Henry WS, Ricq EL, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585(7826):603\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2732-8.","journal-title":"Nature"},{"key":"419_CR89","doi-asserted-by":"publisher","unstructured":"Timpson P. Faculty Opinions recommendation of Lymph protects metastasizing melanoma cells from ferroptosis. Faculty Opinions \u2013 Post-Publication Peer Review of the Biomedical Literature. Published online November. 2020;12. https:\/\/doi.org\/10.3410\/f.738515495.793580094.","DOI":"10.3410\/f.738515495.793580094"},{"key":"419_CR90","doi-asserted-by":"publisher","first-page":"1252567","DOI":"10.3389\/fphar.2023.1252567","volume":"14","author":"N Ta","year":"2023","unstructured":"Ta N, Jiang X, Zhang Y, Wang H. Ferroptosis as a promising therapeutic strategy for melanoma. Front Pharmacol. 2023;14:1252567\u20131252567. https:\/\/doi.org\/10.3389\/fphar.2023.1252567.","journal-title":"Front Pharmacol"},{"key":"419_CR91","doi-asserted-by":"publisher","unstructured":"Mishima E, Nakamura T, Zheng J, et al. DHODH inhibitors sensitize cancer cells to ferroptosis via FSP1 inhibition. Res Square Preprint posted online Oct. 2022;24. https:\/\/doi.org\/10.21203\/rs.3.rs-2190326\/v1.","DOI":"10.21203\/rs.3.rs-2190326\/v1"},{"issue":"7924","key":"419_CR92","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima E, Ito J, Wu Z, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608(7924):778\u201383. https:\/\/doi.org\/10.1038\/s41586-022-05022-3.","journal-title":"Nature"},{"issue":"7969","key":"419_CR93","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","volume":"619","author":"T Nakamura","year":"2023","unstructured":"Nakamura T, Hipp C, Mour\u00e3o A, et al. Phase separation of FSP1 promotes ferroptosis. Nature. 2023;619(7969):371\u20137. https:\/\/doi.org\/10.1038\/s41586-023-06255-6.","journal-title":"Nature"},{"issue":"1","key":"419_CR94","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1038\/s41467-025-58175-w","volume":"16","author":"BF Roeck","year":"2025","unstructured":"Roeck BF, Vorndran MRH, Basavarajappa L, et al. Ferroptosis spreads to neighboring cells via plasma membrane contacts. Nat Commun. 2025;16(1):2951. https:\/\/doi.org\/10.1038\/s41467-025-58175-w.","journal-title":"Nat Commun"},{"issue":"6","key":"419_CR95","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342. https:\/\/doi.org\/10.1038\/s41580-024-00703-5. (PMID: 38366038).","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"419_CR96","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"419_CR97","doi-asserted-by":"publisher","unstructured":"Liang D, Feng Y, Zandkarimi F et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186(13):2748\u20132764.e22. https:\/\/doi.org\/10.1016\/j.cell.2023.05.003 (PMID: 37267948).","DOI":"10.1016\/j.cell.2023.05.003"},{"issue":"7998","key":"419_CR98","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","volume":"626","author":"FP Freitas","year":"2024","unstructured":"Freitas FP, Alborzinia H, Dos Santos AF, et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626(7998):401\u201310. https:\/\/doi.org\/10.1038\/s41586-023-06878-9.","journal-title":"Nature"},{"issue":"1","key":"419_CR99","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou Y, Palte MJ, Deik AA, et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun. 2019;10(1):1617. https:\/\/doi.org\/10.1038\/s41467-019-09277-9.","journal-title":"Nat Commun"},{"issue":"7664","key":"419_CR100","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547(7664):453\u20137. https:\/\/doi.org\/10.1038\/nature23007. (PMID: 28678785).","journal-title":"Nature"},{"issue":"9","key":"419_CR101","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41556-024-01464-1","volume":"26","author":"A Schwab","year":"2024","unstructured":"Schwab A, Rao Z, Zhang J, et al. Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat Cell Biol. 2024;26(9):1470\u201381. https:\/\/doi.org\/10.1038\/s41556-024-01464-1.","journal-title":"Nat Cell Biol"},{"issue":"7679","key":"419_CR102","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551(7679):247\u201350. https:\/\/doi.org\/10.1038\/nature24297.","journal-title":"Nature"},{"issue":"5","key":"419_CR103","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi J, Robert L, Paraiso K, et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell. 2018;33(5):890\u2013e9045. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.017.","journal-title":"Cancer Cell"},{"key":"419_CR104","doi-asserted-by":"publisher","first-page":"966007","DOI":"10.3389\/fmolb.2022.966007","volume":"9","author":"Z Tan","year":"2022","unstructured":"Tan Z, Huang H, Sun W, Li Y, Jia Y. Current progress of ferroptosis study in ovarian cancer. Front Mol Biosci. 2022;9:966007\u2013966007. https:\/\/doi.org\/10.3389\/fmolb.2022.966007.","journal-title":"Front Mol Biosci"},{"key":"419_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/7548406","volume":"2021","author":"R Chen","year":"2021","unstructured":"Chen R, Cao J, Jiang W, Wang S, Cheng J. Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer. J Oncol. 2021;2021:1\u201314. https:\/\/doi.org\/10.1155\/2021\/7548406.","journal-title":"J Oncol"},{"issue":"3","key":"419_CR106","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41419-024-06584-y","volume":"15","author":"L Ye","year":"2024","unstructured":"Ye L, Wen X, Qin J, et al. Metabolism-regulated ferroptosis in cancer progression and therapy. Cell Death Dis. 2024;15(3):196\u2013196. https:\/\/doi.org\/10.1038\/s41419-024-06584-y.","journal-title":"Cell Death Dis"},{"issue":"1","key":"419_CR107","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174\u2013174. https:\/\/doi.org\/10.1186\/s13045-022-01392-3.","journal-title":"J Hematol Oncol"},{"issue":"18","key":"419_CR108","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.7150\/jca.54699","volume":"12","author":"R Huang","year":"2021","unstructured":"Huang R, Chen H, Liang J, et al. Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy. J Cancer. 2021;12(18):5543\u201361. https:\/\/doi.org\/10.7150\/jca.54699.","journal-title":"J Cancer"},{"issue":"1","key":"419_CR109","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","volume":"5","author":"D Li","year":"2020","unstructured":"Li D, Li Y. The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther. 2020;5(1):108\u2013108. https:\/\/doi.org\/10.1038\/s41392-020-00216-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"419_CR110","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12964-020-00663-1","volume":"18","author":"B Tang","year":"2020","unstructured":"Tang B, Zhu J, Li J, et al. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun Signal. 2020;18(1):174\u2013174. https:\/\/doi.org\/10.1186\/s12964-020-00663-1.","journal-title":"Cell Commun Signal"},{"key":"419_CR111","doi-asserted-by":"publisher","first-page":"738477","DOI":"10.3389\/fonc.2021.738477","volume":"11","author":"Z Chen","year":"2021","unstructured":"Chen Z, Tian H, Yao D, Zhang Y, Feng Z, Yang C. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Front Oncol. 2021;11:738477\u2013738477. https:\/\/doi.org\/10.3389\/fonc.2021.738477.","journal-title":"Front Oncol"},{"key":"419_CR112","doi-asserted-by":"publisher","unstructured":"Wu C, Chen X, Zhang Y, et al. A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma. PLoS ONE. 2025;20(6). https:\/\/doi.org\/10.1371\/journal.pone.0322158.","DOI":"10.1371\/journal.pone.0322158"},{"issue":"1","key":"419_CR113","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41420-024-02116-x","volume":"10","author":"X Wu","year":"2024","unstructured":"Wu X, Cao J, Wan X, Du S. Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects. Cell Death Discov. 2024;10(1):356\u2013356. https:\/\/doi.org\/10.1038\/s41420-024-02116-x.","journal-title":"Cell Death Discov"},{"key":"419_CR114","doi-asserted-by":"publisher","unstructured":"Zheng C, Zhang B, Li Y, et al. Donafenib and GSK-J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression. Adv Sci. 2023;10(22). https:\/\/doi.org\/10.1002\/advs.202206798.","DOI":"10.1002\/advs.202206798"},{"key":"419_CR115","doi-asserted-by":"publisher","first-page":"947208","DOI":"10.3389\/fmolb.2022.947208","volume":"9","author":"L Li","year":"2022","unstructured":"Li L, Wang X, Xu H, Liu X, Xu K. Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma. Front Mol Biosci. 2022;9:947208\u2013947208. https:\/\/doi.org\/10.3389\/fmolb.2022.947208.","journal-title":"Front Mol Biosci"},{"issue":"0","key":"419_CR116","doi-asserted-by":"publisher","first-page":"0","DOI":"10.14218\/jcth.2022.00255","volume":"0","author":"Z Huang","year":"2022","unstructured":"Huang Z, Xia H, Cui Y, Yam JWP, Xu Y, Ferroptosis. From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma. J Clin Transl Hepatol. 2022;0(0):0. https:\/\/doi.org\/10.14218\/jcth.2022.00255.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"419_CR117","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/s41467-021-27452-9","volume":"12","author":"F Yao","year":"2021","unstructured":"Yao F, Deng Y, Zhao Y, et al. A targetable LIFR\u2009\u2013\u2009NF-\u03baB\u2013LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun. 2021;12(1):7333\u20137333. https:\/\/doi.org\/10.1038\/s41467-021-27452-9.","journal-title":"Nat Commun"},{"issue":"12","key":"419_CR118","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.neo.2021.11.002","volume":"23","author":"W Huang","year":"2021","unstructured":"Huang W, Chen K, Lu Y, et al. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. Neoplasia. 2021;23(12):1227\u201339. https:\/\/doi.org\/10.1016\/j.neo.2021.11.002.","journal-title":"Neoplasia"},{"key":"419_CR119","doi-asserted-by":"publisher","unstructured":"Zhang D, Man D, Lu J, et al. Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion. Adv Sci. 2023;10(15). https:\/\/doi.org\/10.1002\/advs.202206669.","DOI":"10.1002\/advs.202206669"},{"issue":"8","key":"419_CR120","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1158\/2767-9764.crc-25-0268","volume":"5","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Cai Y, Yuan H, et al. Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy. Cancer Res Commun. 2025;5(8):1288\u201397. https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0268.","journal-title":"Cancer Res Commun"},{"key":"419_CR121","doi-asserted-by":"publisher","first-page":"106739","DOI":"10.1016\/j.phrs.2023.106739","volume":"191","author":"C Xu","year":"2023","unstructured":"Xu C, Jiang Z, Shao L, et al. \u03b2-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer. Pharmacol Res. 2023;191:106739\u2013106739. https:\/\/doi.org\/10.1016\/j.phrs.2023.106739.","journal-title":"Pharmacol Res"},{"key":"419_CR122","doi-asserted-by":"publisher","first-page":"1360638","DOI":"10.3389\/fonc.2024.1360638","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, Li X, Li J. Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies. Front Oncol. 2024;14:1360638\u20131360638. https:\/\/doi.org\/10.3389\/fonc.2024.1360638.","journal-title":"Front Oncol"},{"issue":"7","key":"419_CR123","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41419-022-05070-7","volume":"13","author":"L Yang","year":"2022","unstructured":"Yang L, Cao L, Zhang X, Chu B. Targeting ferroptosis as a vulnerability in pulmonary diseases. Cell Death Dis. 2022;13(7):649\u2013649. https:\/\/doi.org\/10.1038\/s41419-022-05070-7.","journal-title":"Cell Death Dis"},{"issue":"1","key":"419_CR124","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41420-023-01407-z","volume":"9","author":"N Xing","year":"2023","unstructured":"Xing N, Du Q, Guo S, et al. Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy. Cell Death Discov. 2023;9(1):110\u2013110. https:\/\/doi.org\/10.1038\/s41420-023-01407-z.","journal-title":"Cell Death Discov"},{"issue":"1","key":"419_CR125","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41420-023-01383-4","volume":"9","author":"F Maccarinelli","year":"2023","unstructured":"Maccarinelli F, Coltrini D, Mussi S, et al. Iron supplementation enhances RSL3-induced ferroptosis to treat na\u00efve and prevent castration-resistant prostate cancer. Cell Death Discov. 2023;9(1):81\u201381. https:\/\/doi.org\/10.1038\/s41420-023-01383-4.","journal-title":"Cell Death Discov"},{"issue":"7","key":"419_CR126","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1021\/acsnano.4c16981","volume":"19","author":"XQ Cheng","year":"2025","unstructured":"Cheng XQ, Xu J, Cui Y, et al. Nanovesicles for Lipid Metabolism Reprogram-Enhanced Ferroptosis and Magnetotherapy of Refractory Tumors and Inhibiting Metastasis with Activated Innate Immunity. ACS Nano. 2025;19(7):7213\u201330. https:\/\/doi.org\/10.1021\/acsnano.4c16981.","journal-title":"ACS Nano"},{"issue":"8","key":"419_CR127","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2020","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2020;12(8):599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5.","journal-title":"Protein Cell"},{"issue":"24","key":"419_CR128","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.2174\/0929867329666220111120924","volume":"29","author":"N Zaffaroni","year":"2022","unstructured":"Zaffaroni N, Beretta GL. Ferroptosis Inducers for Prostate Cancer Therapy. Curr Med Chem. 2022;29(24):4185\u2013201. https:\/\/doi.org\/10.2174\/0929867329666220111120924.","journal-title":"Curr Med Chem"},{"issue":"1","key":"419_CR129","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1038\/s41467-020-16126-7","volume":"11","author":"A Blomme","year":"2020","unstructured":"Blomme A, Ford CA, Mui E, et al. 2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer. Nat Commun. 2020;11(1):2508\u20132508. https:\/\/doi.org\/10.1038\/s41467-020-16126-7.","journal-title":"Nat Commun"},{"key":"419_CR130","doi-asserted-by":"publisher","unstructured":"Nassar ZD, Mah CY, Dehairs J, et al. Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. Elife. 2020;9. https:\/\/doi.org\/10.7554\/elife.54166.","DOI":"10.7554\/elife.54166"},{"key":"419_CR131","doi-asserted-by":"publisher","unstructured":"Ai L, Yi N, Qiu C, et al. Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review). Int J Oncol. 2024;64(5). https:\/\/doi.org\/10.3892\/ijo.2024.5634.","DOI":"10.3892\/ijo.2024.5634"},{"key":"419_CR132","doi-asserted-by":"publisher","unstructured":"Wang Y, Liu T, Li X, Sheng H, Ma X, Liang H. Ferroptosis-Inducing Nanomedicine for Cancer Therapy. Front Pharmacol. 2021;12. https:\/\/doi.org\/10.3389\/fphar.2021.735965.","DOI":"10.3389\/fphar.2021.735965"},{"issue":"9","key":"419_CR133","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00018-023-04907-4","volume":"80","author":"Y Ren","year":"2023","unstructured":"Ren Y, Mao X, Xu H, et al. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance. Cell Mol Life Sci. 2023;80(9):263\u2013263. https:\/\/doi.org\/10.1007\/s00018-023-04907-4.","journal-title":"Cell Mol Life Sci"},{"key":"419_CR134","doi-asserted-by":"publisher","first-page":"1243286","DOI":"10.3389\/fphar.2023.1243286","volume":"14","author":"C Xu","year":"2023","unstructured":"Xu C, Chen Y, Yu Q, Song J, Jin Y, Gao X. Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential. Front Pharmacol. 2023;14:1243286\u20131243286. https:\/\/doi.org\/10.3389\/fphar.2023.1243286.","journal-title":"Front Pharmacol"},{"issue":"17","key":"419_CR135","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.7150\/thno.59092","volume":"11","author":"MJ Morales","year":"2021","unstructured":"Morales MJ, Xue X. Targeting iron metabolism in cancer therapy. Theranostics. 2021;11(17):8412\u201329. https:\/\/doi.org\/10.7150\/thno.59092.","journal-title":"Theranostics"},{"key":"419_CR136","doi-asserted-by":"publisher","first-page":"1588668","DOI":"10.3389\/fonc.2025.1588668","volume":"15","author":"X Ye","year":"2025","unstructured":"Ye X, Ju X. Natural products targeting ferroptosis in cancer: molecular mechanisms and applications. Front Oncol. 2025;15:1588668\u20131588668. https:\/\/doi.org\/10.3389\/fonc.2025.1588668.","journal-title":"Front Oncol"},{"key":"419_CR137","doi-asserted-by":"publisher","first-page":"1374722","DOI":"10.3389\/fphar.2024.1374722","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xie J. Targeting ferroptosis regulators by natural products in colorectal cancer. Front Pharmacol. 2024;15:1374722\u20131374722. https:\/\/doi.org\/10.3389\/fphar.2024.1374722.","journal-title":"Front Pharmacol"},{"key":"419_CR138","doi-asserted-by":"publisher","first-page":"902302","DOI":"10.3389\/fphar.2022.902302","volume":"13","author":"L L\u00fc","year":"2022","unstructured":"L\u00fc L, Chen B, Xu Y, et al. Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer. Front Pharmacol. 2022;13:902302\u2013902302. https:\/\/doi.org\/10.3389\/fphar.2022.902302.","journal-title":"Front Pharmacol"},{"issue":"6","key":"419_CR139","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41419-022-04927-1","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang D, Tang L, Zhang Y, et al. Regulatory pathways and drugs associated with ferroptosis in tumors. Cell Death Dis. 2022;13(6):544\u2013544. https:\/\/doi.org\/10.1038\/s41419-022-04927-1.","journal-title":"Cell Death Dis"},{"issue":"1","key":"419_CR140","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43\u201343. https:\/\/doi.org\/10.1186\/s12943-020-01168-8.","journal-title":"Mol Cancer"},{"key":"419_CR141","doi-asserted-by":"publisher","first-page":"1289335","DOI":"10.3389\/fcell.2024.1289335","volume":"12","author":"Z Yue","year":"2024","unstructured":"Yue Z, Yuan Y, Zhou Q, Sheng J, Lin X. Ferroptosis and its current progress in gastric cancer. Front Cell Dev Biol. 2024;12:1289335\u20131289335. https:\/\/doi.org\/10.3389\/fcell.2024.1289335.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"419_CR142","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","volume":"16","author":"E Dai","year":"2020","unstructured":"Dai E, Han L, Liu J, et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 2020;16(11):2069\u201383. https:\/\/doi.org\/10.1080\/15548627.2020.1714209.","journal-title":"Autophagy"},{"key":"419_CR143","doi-asserted-by":"publisher","first-page":"733751","DOI":"10.3389\/fcell.2021.733751","volume":"9","author":"S Wu","year":"2021","unstructured":"Wu S, Li T, Liu W, Huang Y. Ferroptosis and Cancer: Complex Relationship and Potential Application of Exosomes. Front Cell Dev Biol. 2021;9:733751\u2013733751. https:\/\/doi.org\/10.3389\/fcell.2021.733751.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"419_CR144","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1021\/acs.jmedchem.0c01936","volume":"64","author":"Y Gou","year":"2021","unstructured":"Gou Y, Chen M, Li S, et al. Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer. J Med Chem. 2021;64(9):5485\u201399. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01936.","journal-title":"J Med Chem"},{"issue":"1","key":"419_CR145","doi-asserted-by":"publisher","first-page":"1699375","DOI":"10.1080\/23723556.2019.1699375","volume":"7","author":"W Yang","year":"2019","unstructured":"Yang W, Chi J. Hippo pathway effectors YAP\/TAZ as novel determinants of ferroptosis. Mol Cell Oncol. 2019;7(1):1699375\u20131699375. https:\/\/doi.org\/10.1080\/23723556.2019.1699375.","journal-title":"Mol Cell Oncol"},{"issue":"10","key":"419_CR146","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","volume":"28","author":"W Yang","year":"2019","unstructured":"Yang W, Ding CC, Sun T, et al. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. Cell Rep. 2019;28(10):2501. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.107.","journal-title":"Cell Rep"},{"key":"419_CR147","doi-asserted-by":"publisher","first-page":"1065994","DOI":"10.3389\/fonc.2023.1065994","volume":"13","author":"H Chi","year":"2023","unstructured":"Chi H, Li B, Wang Q, et al. Opportunities and challenges related to ferroptosis in glioma and neuroblastoma. Front Oncol. 2023;13:1065994\u20131065994. https:\/\/doi.org\/10.3389\/fonc.2023.1065994.","journal-title":"Front Oncol"},{"issue":"14","key":"419_CR148","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/cells12141820","volume":"12","author":"R Zhang","year":"2023","unstructured":"Zhang R, Chen J, Wang S, Zhang W, Zheng Q, Cai R. Ferroptosis Cancer Progression Cells. 2023;12(14):1820\u20131820. https:\/\/doi.org\/10.3390\/cells12141820.","journal-title":"Ferroptosis Cancer Progression Cells"},{"issue":"7769","key":"419_CR149","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2\u2013YAP signalling. Nature. 2019;572(7769):402\u20136. https:\/\/doi.org\/10.1038\/s41586-019-1426-6.","journal-title":"Nature"},{"key":"419_CR150","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3049","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023. https:\/\/doi.org\/10.1126\/scitranslmed.adg3049.","journal-title":"Sci Transl Med"},{"issue":"1","key":"419_CR151","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai E, Han L, Liu J, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat Commun. 2020;11(1):6339. https:\/\/doi.org\/10.1038\/s41467-020-20154-8.","journal-title":"Nat Commun"},{"issue":"3","key":"419_CR152","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/antiox15030382","volume":"15","author":"E Giorgio","year":"2026","unstructured":"Giorgio E, Galeano C, Natali G, et al. Interaction of ferroptosis and immune-mediated inflammation in psoriasis. Antioxid (Basel). 2026;15(3):382. https:\/\/doi.org\/10.3390\/antiox15030382.","journal-title":"Antioxid (Basel)"},{"key":"419_CR153","doi-asserted-by":"publisher","first-page":"613534","DOI":"10.3389\/fcell.2021.613534","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, Yang Q, Tan Y, et al. Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin. Front Cell Dev Biol. 2021;9:613534\u2013613534. https:\/\/doi.org\/10.3389\/fcell.2021.613534.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"419_CR154","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-024-06930-0","volume":"15","author":"H Wu","year":"2024","unstructured":"Wu H, Fu M, Wu M, Cao Z, Zhang Q, Liu Z. Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Cell Death Dis. 2024;15(8):553\u2013553. https:\/\/doi.org\/10.1038\/s41419-024-06930-0.","journal-title":"Cell Death Dis"},{"issue":"4","key":"419_CR155","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.7150\/thno.89805","volume":"14","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Fang S, Fan B, et al. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer. Theranostics. 2024;14(4):1683\u2013700. https:\/\/doi.org\/10.7150\/thno.89805.","journal-title":"Theranostics"},{"key":"419_CR156","doi-asserted-by":"publisher","first-page":"1372330","DOI":"10.3389\/fcell.2024.1372330","volume":"12","author":"H Su","year":"2024","unstructured":"Su H, Peng C, Liu Y. Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer. Front Cell Dev Biol. 2024;12:1372330\u20131372330. https:\/\/doi.org\/10.3389\/fcell.2024.1372330.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"419_CR157","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev-pathmechdis-031521-022116","volume":"18","author":"J Clancy","year":"2022","unstructured":"Clancy J, D\u2019Souza-Schorey C. Tumor-Derived Extracellular Vesicles: Multifunctional Entities in the Tumor Microenvironment. Annu Rev Pathol. 2022;18(1):205\u201329. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-022116.","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"419_CR158","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723\u201337. https:\/\/doi.org\/10.1038\/nri3073.","journal-title":"Nat Rev Immunol"},{"key":"419_CR159","doi-asserted-by":"publisher","first-page":"1658280","DOI":"10.3389\/fimmu.2025.1658280","volume":"16","author":"S Chen","year":"2025","unstructured":"Chen S, Ma J, Tang J, Yang Y, Zhou S, Feng P. Research progress of macrophage ferroptosis in inflammatory bowel disease and inflammation-cancer transformation. Front Immunol. 2025;16:1658280\u20131658280. https:\/\/doi.org\/10.3389\/fimmu.2025.1658280.","journal-title":"Front Immunol"},{"issue":"1","key":"419_CR160","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang Y, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196\u2013196. https:\/\/doi.org\/10.1038\/s41392-022-01046-3.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"419_CR161","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, He L, Zhu J, Zhang P, Liang S. Targeting tumor-associated macrophages for cancer treatment. Cell Biosci. 2022;12(1):85\u201385. https:\/\/doi.org\/10.1186\/s13578-022-00823-5.","journal-title":"Cell Biosci"},{"issue":"1","key":"419_CR162","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12964-023-01408-6","volume":"22","author":"K H\u00e1n\u011blov\u00e1","year":"2024","unstructured":"H\u00e1n\u011blov\u00e1 K, Raudensk\u00e1 M, Masa\u0159\u00edk M, Balvan J. Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. Cell Commun Signal. 2024;22(1):25\u201325. https:\/\/doi.org\/10.1186\/s12964-023-01408-6.","journal-title":"Cell Commun Signal"},{"key":"419_CR163","doi-asserted-by":"publisher","first-page":"739392","DOI":"10.3389\/fcell.2021.739392","volume":"9","author":"Y Liu","year":"2021","unstructured":"Liu Y, Duan C, Dai R, Zeng Y. Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy. Front Cell Dev Biol. 2021;9:739392\u2013739392. https:\/\/doi.org\/10.3389\/fcell.2021.739392.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"419_CR164","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1158\/0008-5472.can-24-1941","volume":"85","author":"W Zeng","year":"2024","unstructured":"Zeng W, Zhang R, Huang P, et al. Ferroptotic Neutrophils Induce Immunosuppression and Chemoresistance in Breast Cancer. Cancer Res. 2024;85(3):477\u201396. https:\/\/doi.org\/10.1158\/0008-5472.can-24-1941.","journal-title":"Cancer Res"},{"key":"419_CR165","unstructured":"Kim R. March. Ferroptosis of tumor neutrophils causes immune suppression in cancer. ScholarlyCommons (University of Pennsylvania). Published online January 1, 2023. Accessed 2026. https:\/\/repository.upenn.edu\/handle\/20.500.14332\/59112"},{"key":"419_CR166","doi-asserted-by":"publisher","first-page":"715234","DOI":"10.3389\/fimmu.2021.715234","volume":"12","author":"JS Dolina","year":"2021","unstructured":"Dolina JS, Budimir N, Thomas GD, Salek-Ardakani S. CD8\u2009+\u2009T Cell Exhaustion in Cancer. Front Immunol. 2021;12:715234\u2013715234. https:\/\/doi.org\/10.3389\/fimmu.2021.715234.","journal-title":"Front Immunol"},{"issue":"1","key":"419_CR167","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41420-025-02744-x","volume":"11","author":"S Singh","year":"2025","unstructured":"Singh S, Mohapatra I, Barik D, et al. Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance. Cell Death Discov. 2025;11(1):448\u2013448. https:\/\/doi.org\/10.1038\/s41420-025-02744-x.","journal-title":"Cell Death Discov"},{"issue":"1","key":"419_CR168","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40164-023-00427-w","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng X, Jin X, Ye F, et al. Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy. Exp Hematol Oncol. 2023;12(1):65\u201365. https:\/\/doi.org\/10.1186\/s40164-023-00427-w.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"419_CR169","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10142-024-01292-4","volume":"24","author":"D Jin","year":"2024","unstructured":"Jin D, Hui Y, Liu D, et al. LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3\/SLC7A11 in hepatocellular carcinoma. Funct Integr Genomics. 2024;24(1):29\u201329. https:\/\/doi.org\/10.1007\/s10142-024-01292-4.","journal-title":"Funct Integr Genomics"},{"issue":"6","key":"419_CR170","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/cancers15061743","volume":"15","author":"KM Coyle","year":"2023","unstructured":"Coyle KM, Hawke LG, Ormiston ML. Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics. Cancers. 2023;15(6):1743\u20131743. https:\/\/doi.org\/10.3390\/cancers15061743.","journal-title":"Cancers"},{"key":"419_CR171","doi-asserted-by":"publisher","first-page":"102923","DOI":"10.1016\/j.redox.2023.102923","volume":"67","author":"L Yao","year":"2023","unstructured":"Yao L, Hou J, Wu X, et al. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. PubMed Cent. 2023;67:102923\u2013102923. https:\/\/doi.org\/10.1016\/j.redox.2023.102923.","journal-title":"PubMed Cent"},{"issue":"2","key":"419_CR172","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021.","journal-title":"Cell"},{"issue":"5","key":"419_CR173","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","volume":"14","author":"MM Gaschler","year":"2018","unstructured":"Gaschler MM, Andia AA, Liu H, et al. FINO\u2082 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018;14(5):507\u201315. https:\/\/doi.org\/10.1038\/s41589-018-0031-6.","journal-title":"Nat Chem Biol"},{"issue":"7","key":"419_CR174","doi-asserted-by":"publisher","first-page":"39675","DOI":"10.31083\/FBL39675","volume":"30","author":"L Petriaggi","year":"2025","unstructured":"Petriaggi L, Giorgio E, Natali G, et al. Iron fist in a velvet glove: Class IV ferroptosis inducers as a novel strategy to target ovarian cancer. Front Biosci (Landmark Ed). 2025;30(7):39675. https:\/\/doi.org\/10.31083\/FBL39675.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"8","key":"419_CR175","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.3390\/ijms26083852","volume":"26","author":"MK Singh","year":"2025","unstructured":"Singh MK, Arora H, Naik R, et al. Ferroptosis in Cancer: Mechanism and Therapeutic Potential. Int J Mol Sci. 2025;26(8):3852\u20133852. https:\/\/doi.org\/10.3390\/ijms26083852.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"419_CR176","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/cbin.11121","volume":"43","author":"Q Liu","year":"2019","unstructured":"Liu Q, Wang K. The induction of ferroptosis by impairing STAT3\/Nrf2\/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. Cell Biol Int. 2019;43(11):1245\u201356. https:\/\/doi.org\/10.1002\/cbin.11121.","journal-title":"Cell Biol Int"},{"key":"419_CR177","doi-asserted-by":"publisher","first-page":"1688181","DOI":"10.3389\/fimmu.2025.1688181","volume":"16","author":"H Dong","year":"2025","unstructured":"Dong H, Ye C, Yu X, Shao Y. Non-coding RNAs in gastric cancer immunotherapy: mechanisms and clinical implications. Front Immunol. 2025;16:1688181\u20131688181. https:\/\/doi.org\/10.3389\/fimmu.2025.1688181.","journal-title":"Front Immunol"},{"issue":"1","key":"419_CR178","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1038\/s41467-025-65056-9","volume":"16","author":"C Tang","year":"2025","unstructured":"Tang C, He C, Wang D, et al. Co-delivery of sorafenib and an FSP1 inhibitor triggers dual ferroptosis in tumor cells and immunosuppressive macrophages for enhanced immunotherapy in mouse models of hepatocellular carcinoma. Nat Commun. 2025;16(1):10096\u201310096. https:\/\/doi.org\/10.1038\/s41467-025-65056-9.","journal-title":"Nat Commun"},{"issue":"20","key":"419_CR179","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.3390\/ijms222010944","volume":"22","author":"J Yang","year":"2021","unstructured":"Yang J, Xu J, Zhang B, et al. Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer. Int J Mol Sci. 2021;22(20):10944\u201310944. https:\/\/doi.org\/10.3390\/ijms222010944.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"419_CR180","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.21873\/anticanres.12046","volume":"37","author":"S Slez\u00e1kov\u00e1","year":"2017","unstructured":"Slez\u00e1kov\u00e1 S, Ku\u010derov\u00e1 J. Anticancer Activity of Artemisinin and its Derivatives. Anticancer Res. 2017;37(11):5995\u20136003. https:\/\/doi.org\/10.21873\/anticanres.12046.","journal-title":"Anticancer Res"},{"key":"419_CR181","doi-asserted-by":"publisher","unstructured":"Wang Z, Li R, Hou N, et al. PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis. J Immunother Cancer. 2023;11(6). https:\/\/doi.org\/10.1136\/jitc-2023-006890.","DOI":"10.1136\/jitc-2023-006890"},{"issue":"24","key":"419_CR182","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1158\/0008-5472.can-21-1547","volume":"81","author":"F Fan","year":"2021","unstructured":"Fan F, Liu P, Bao R, et al. A Dual PI3K\/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy. Cancer Res. 2021;81(24):6233\u201345. https:\/\/doi.org\/10.1158\/0008-5472.can-21-1547.","journal-title":"Cancer Res"},{"key":"419_CR183","doi-asserted-by":"publisher","unstructured":"Fan R, Deng A, Lin R, et al. A platinum(IV)\u2013artesunate complex triggers ferroptosis by boosting cytoplasmic and mitochondrial lipid peroxidation to enhance tumor immunotherapy. MedComm. 2024;5(6). https:\/\/doi.org\/10.1002\/mco2.570.","DOI":"10.1002\/mco2.570"},{"key":"419_CR184","doi-asserted-by":"publisher","first-page":"1216733","DOI":"10.3389\/fmolb.2023.1216733","volume":"10","author":"GL Beretta","year":"2023","unstructured":"Beretta GL, Zaffaroni N. Radiotherapy-induced ferroptosis for cancer treatment. Front Mol Biosci. 2023;10:1216733\u20131216733. https:\/\/doi.org\/10.3389\/fmolb.2023.1216733.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"419_CR185","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","volume":"7","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct Target Ther. 2022;7(1):258\u2013258. https:\/\/doi.org\/10.1038\/s41392-022-01102-y.","journal-title":"Signal Transduct Target Ther"},{"key":"419_CR186","doi-asserted-by":"publisher","first-page":"1124412","DOI":"10.3389\/fonc.2023.1124412","volume":"13","author":"H Tang","year":"2023","unstructured":"Tang H, Cai L, He X, et al. Radiation-induced bystander effect and its clinical implications. Front Oncol. 2023;13:1124412\u20131124412. https:\/\/doi.org\/10.3389\/fonc.2023.1124412.","journal-title":"Front Oncol"},{"issue":"1","key":"419_CR187","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12951-025-03879-w","volume":"24","author":"Z Hu","year":"2025","unstructured":"Hu Z, Li H, Gan K, et al. Active-targeting biomimetic nanosystem for prostate cancer enhances radiotherapy efficacy by inducing ferroptosis. J Nanobiotechnol. 2025;24(1):9\u20139. https:\/\/doi.org\/10.1186\/s12951-025-03879-w.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"419_CR188","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-021-01346-2","volume":"20","author":"T Briolay","year":"2021","unstructured":"Briolay T, Petithomme T, Fouet M, Nguyen-Pham N, Blanquart C, Boisgerault N. Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Mol Cancer. 2021;20(1):55\u201355. https:\/\/doi.org\/10.1186\/s12943-021-01346-2.","journal-title":"Mol Cancer"},{"issue":"5","key":"419_CR189","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/17425247.2019.1604679","volume":"16","author":"S Biffi","year":"2019","unstructured":"Biffi S, Voltan R, Bortot B, Zauli G, Secchiero P. Actively targeted nanocarriers for drug delivery to cancer cells. Expert Opin Drug Deliv. 2019;16(5):481\u201396. https:\/\/doi.org\/10.1080\/17425247.2019.1604679.","journal-title":"Expert Opin Drug Deliv"},{"key":"419_CR190","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao Y, Zhou Y, Liu L, et al. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci. 2020;7:193\u2013193. https:\/\/doi.org\/10.3389\/fmolb.2020.00193.","journal-title":"Front Mol Biosci"},{"issue":"7","key":"419_CR191","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.bioactmat.2020.12.010","volume":"6","author":"M Yang","year":"2020","unstructured":"Yang M, Li J, Gu P, Fan X. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioact Mater. 2020;6(7):1973\u201387. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.12.010.","journal-title":"Bioact Mater"},{"issue":"1","key":"419_CR192","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang R, Xu J, Zhang B, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13(1):110\u2013110. https:\/\/doi.org\/10.1186\/s13045-020-00946-7.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"419_CR193","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","volume":"25","author":"F Klemm","year":"2014","unstructured":"Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol. 2014;25(4):198\u2013213. https:\/\/doi.org\/10.1016\/j.tcb.2014.11.006.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"419_CR194","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.trecan.2019.02.003","volume":"5","author":"N Chatterjee","year":"2019","unstructured":"Chatterjee N, Bivona TG. Polytherapy and Targeted Cancer Drug Resistance. Trends Cancer. 2019;5(3):170\u201382. https:\/\/doi.org\/10.1016\/j.trecan.2019.02.003.","journal-title":"Trends Cancer"},{"key":"419_CR195","doi-asserted-by":"publisher","unstructured":"Pao W, Miller VA, Politi K, et al. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain. PLoS Med. 2005;2(3). https:\/\/doi.org\/10.1371\/journal.pmed.0020073.","DOI":"10.1371\/journal.pmed.0020073"},{"issue":"1","key":"419_CR196","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-017-0648-1","volume":"16","author":"Z Yang","year":"2017","unstructured":"Yang Z, Hu X, Liu Y, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16(1):79\u201379. https:\/\/doi.org\/10.1186\/s12943-017-0648-1.","journal-title":"Mol Cancer"},{"issue":"1","key":"419_CR197","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-023-01831-w","volume":"22","author":"Y Ren","year":"2023","unstructured":"Ren Y, Wang R, Weng S, et al. Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis. Mol Cancer. 2023;22(1):130\u2013130. https:\/\/doi.org\/10.1186\/s12943-023-01831-w.","journal-title":"Mol Cancer"},{"issue":"1","key":"419_CR198","doi-asserted-by":"publisher","first-page":"37","DOI":"10.58567\/ci03010001","volume":"3","author":"C Liu","year":"2023","unstructured":"Liu C, Ren L. Enhanced understanding of the involvement of ferroptosis in tumorigenesis: A review of recent research advancements. Cancer Insight. 2023;3(1):37\u201348. https:\/\/doi.org\/10.58567\/ci03010001.","journal-title":"Cancer Insight"},{"issue":"12","key":"419_CR199","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41419-019-2143-7","volume":"10","author":"M Gagliardi","year":"2019","unstructured":"Gagliardi M, Cotella D, Santoro C, et al. Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. Cell Death Dis. 2019;10(12):902\u2013902. https:\/\/doi.org\/10.1038\/s41419-019-2143-7.","journal-title":"Cell Death Dis"},{"issue":"1","key":"419_CR200","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3892\/or.2020.7836","volume":"45","author":"Y Luo","year":"2020","unstructured":"Luo Y, Huang Q, He B, Liu Y, Huang S, Xiao J. Regulation of ferroptosis by non\u2013coding RNAs in the development and treatment of cancer (Review). Oncol Rep. 2020;45(1):29\u201348. https:\/\/doi.org\/10.3892\/or.2020.7836.","journal-title":"Oncol Rep"},{"key":"419_CR201","doi-asserted-by":"publisher","first-page":"1156538","DOI":"10.3389\/fphar.2023.1156538","volume":"14","author":"L Yang","year":"2023","unstructured":"Yang L, Zhang X, Wang Z, Li B, Zhu H. Modulation of redox homeostasis: A strategy to overcome cancer drug resistance. Front Pharmacol. 2023;14:1156538\u20131156538. https:\/\/doi.org\/10.3389\/fphar.2023.1156538.","journal-title":"Front Pharmacol"},{"key":"419_CR202","doi-asserted-by":"publisher","first-page":"1344290","DOI":"10.3389\/fonc.2024.1344290","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang H, Chen N, Ding C, Zhang H, Liu D, Liu S. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay. Front Oncol. 2024;14:1344290\u20131344290. https:\/\/doi.org\/10.3389\/fonc.2024.1344290.","journal-title":"Front Oncol"},{"issue":"1","key":"419_CR203","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41420-024-01863-1","volume":"10","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Yu Y, Pan Z, Glandorff C, Sun M. Ferroptosis: a new hunter of hepatocellular carcinoma. Cell Death Discov. 2024;10(1):136\u2013136. https:\/\/doi.org\/10.1038\/s41420-024-01863-1.","journal-title":"Cell Death Discov"},{"issue":"1","key":"419_CR204","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s40820-025-01862-6","volume":"18","author":"XX Wei","year":"2025","unstructured":"Wei XX, Jiang Y, Chenwu F, et al. Synergistic Ferroptosis\u2013Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization. Nano Micro Lett. 2025;18(1):56\u201356. https:\/\/doi.org\/10.1007\/s40820-025-01862-6.","journal-title":"Nano Micro Lett"},{"key":"419_CR205","doi-asserted-by":"publisher","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019;31(51). https:\/\/doi.org\/10.1002\/adma.201904197.","DOI":"10.1002\/adma.201904197"},{"key":"419_CR206","doi-asserted-by":"publisher","first-page":"1657905","DOI":"10.3389\/fimmu.2025.1657905","volume":"16","author":"X Li","year":"2025","unstructured":"Li X, Bo Y, Xue D, Qin L. Ferroptosis-immune crosstalk in cervical cancer: mechanisms and therapeutic implications. Front Immunol. 2025;16:1657905\u20131657905. https:\/\/doi.org\/10.3389\/fimmu.2025.1657905.","journal-title":"Front Immunol"},{"issue":"4","key":"419_CR207","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41419-023-05787-z","volume":"14","author":"TN Xavier da Silva","year":"2023","unstructured":"Xavier da Silva TN, Schulte C, Alves AN, Maric HM, Friedmann Angeli JP. Molecular characterization of AIFM2\/FSP1 inhibition by iFSP1-like molecules. Cell Death Dis. 2023;14(4):281. https:\/\/doi.org\/10.1038\/s41419-023-05787-z.","journal-title":"Cell Death Dis"},{"key":"419_CR208","doi-asserted-by":"publisher","unstructured":"Shen G, Liu J, Wang Y, Deng Z, Deng F. Ferroptosis in Cancer and Inflammatory Diseases: Mechanisms and Therapeutic Implications. MedComm. 2025;6(9). https:\/\/doi.org\/10.1002\/mco2.70349.","DOI":"10.1002\/mco2.70349"},{"issue":"6486","key":"419_CR209","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368(6486):85\u20139. https:\/\/doi.org\/10.1126\/science.aaw9872. (PMID: 32241947).","journal-title":"Science"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00419-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:02:32Z","timestamp":1792260152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00419-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":209,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00419-x","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"6 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article is a narrative review of previously published literature and does not involve human participants, patient data, human tissue samples, or animal experiments. Therefore, ethical approval and informed consent were not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"80"}}